In The News

BioCentury: Medical Excellence to fund cell, gene therapy, AI and regenerative medicine with $145M debut fund

Wall Street Journal: Life Sciences Venture Investor MEC Raises $145 Million Fund

ALS News Today: ProJenX Launches, Will Develop ALS Therapy Prosetin

MEC SAB in the News: Fastest DNA sequencing technique helps undiagnosed patients find answers in mere hours

Endpoints News: Out to prove the next big I/O target, Immunitas’ chief dealmaker steps up to CEO role

FinSMEs: Immunitas Therapeutics Closes $58M in Series B Financing

Endpoints: Touting CD161 as a test case for single-cell tech, Longwood-backed Immunitas bags $58M for next-gen I/O work

Stanford Medicine: Euan Ashley Appointed the Roger W. and Joelle G. Burnell Professor of Genomics and Precision Health